Zoccali Carmine, Abd ElHafeez Samar, Dounousi Evangelia, Anastasi Rossana, Tripepi Giovanni, Mallamaci Francesca
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(2):85-90. doi: 10.1515/prilozi-2015-0056.
CKD is a problem of epidemic dimension. The risk of death and cardiovascular complications in this condition is of the same order of that by myocardial infarction, which qualifies CKD as "risk equivalent". Calculations made on the basis of the epidemiological data of the MONICA-Augsburg study and analyses of the costs of myocardial infarction in a large health insurance company in Germany show that the economic burden of cardiovascular comorbidities with CKD in this country is substantial. These estimates, which may be valid also for other large member states of the European Community, represent a call for studies looking at the cost-effectiveness of preventive interventions aimed at reducing the risk for CKD and at lowering the concerning incidence rate of death and disability due to CKD-triggered cardiovascular complications in CKD patients.
慢性肾脏病是一个具有流行规模的问题。在这种情况下，死亡风险和心血管并发症与心肌梗死相当，这使慢性肾脏病成为“风险等同物”。根据莫妮卡-奥格斯堡研究的流行病学数据以及对德国一家大型健康保险公司心肌梗死成本的分析得出的计算结果表明，该国慢性肾脏病合并心血管疾病的经济负担相当大。这些估计可能对欧洲共同体的其他大型成员国也有效，这呼吁开展研究，探讨旨在降低慢性肾脏病风险以及降低慢性肾脏病患者因慢性肾脏病引发的心血管并发症导致的死亡和残疾发生率的预防性干预措施的成本效益。
